CCL18 and atherosclerosis: Fourth, CCL18 administration in hyperlipidemic CCR6−/− mice neither did aggravate atherosclerosis nor did induce T-cell accumulation in plaque, unlike WT mice that rendered hyperlipidemic by PCSK9 gene transfer.